1st Quarter - Report

DAVITA INC. for DAVITA INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$1,480,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2020 $1,480,000 Replaced
1st Quarter - Amendment Oct 20, 2020 $1,540,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Dialysis PATIENTS Demonstration Act, all provisions (no bill number this Congress) CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act H.R. 1224, The Living Donor Protection Act, all provisions Issues related to Chronic Kidney Disease and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients S.1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019, all provisions ESRD Treatment Choices (ETC) Mandatory Demonstration H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act Worked with HHS, CMS and FEMA on emergency response related to COVID-19

LobbyistCovered position, as disclosed
JAVIER DEJESUS BARAJAS MARTINEZ —
KELLY PHILSON —
DAVID SANDERS —
JOELLE OISHI THORNHILL —
LEANNE M ZUMWALT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 748 (116th), S. 1676 (116th), H.R. 1224 (116th)

Medicare/Medicaid MMM

Dialysis PATIENTS Demonstration Act, all provisions (no bill number this Congress) CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act H.R. 1224, The Living Donor Protection Act, all provisions Issues related to Chronic Kidney Disease and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients S.1676, Chronic Kidney Disease Improvement in Research and Treatment Act of 2019, all provisions ESRD Treatment Choices (ETC) Mandatory Demonstration H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act Worked with HHS, CMS and FEMA on emergency response related to COVID-19

LobbyistCovered position, as disclosed
JAVIER DEJESUS BARAJAS MARTINEZ —
KELLY PHILSON —
DAVID SANDERS —
JOELLE OISHI THORNHILL —
LEANNE M ZUMWALT —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 748 (116th), H.R. 1224 (116th), S. 1676 (116th)

Veterans VET

Issues related to Veterans Affairs and dialysis

LobbyistCovered position, as disclosed
JAVIER DEJESUS BARAJAS MARTINEZ —
DAVID SANDERS —
JOELLE OISHI THORNHILL —
LEANNE M ZUMWALT —

Contacted: Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.